[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
Régis
A
A
Ben Salem
D
D
Lambert
A
A
Couaillier
J F
JF
Casasnovas
O
O
Piard
F
F
Krausé
D
D
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D001761:Bleomycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005500:Follow-Up Studies; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008168:Lung / Q000473:pathology; D008224:Lymphoma, Follicular / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D013902:Radiography, Thoracic; D011879:Radiotherapy Dosage; D012074:Remission Induction; D016540:Smoking Cessation; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone